中医药调控GR/NF -κB/NLRP3信号通路治疗抑郁症的研究进展
DOI:
作者:
作者单位:

1.河南中医药大学中医学院;2.河南中医药大学;3.郑州大学第一附属医院

作者简介:

通讯作者:

中图分类号:

基金项目:

河南省高等学校重点科研项目(18A360002);河南省“双一流”创建工程中医学学科项目(HSRP-DFCTCM-2023-1-18)


Research progress of traditional Chinese medicine regulating GR/ NF-κB /NLRP3 signaling pathway in the treatment of depression
Author:
Affiliation:

1.College of Traditional Chinese Medicine, Henan University of Traditional Chinese Medicine;2.Henan University of Traditional Chinese Medicine;3.The First Affiliated Hospital of Zhengzhou University

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    抑郁症(Major Depressive Disorder, MDD)是导致自杀的主要原因之一。单胺类药物是治疗该疾病的主要方式,但其疗效有限,这也凸显了改进治疗方法的迫切需求。中医药在这一领域展现出多重作用机制、较少副作用等优势,成为一种具有潜力的治疗选择。近年来,GR/NF-κB/NLRP3信号通路在抑郁症治疗中的重要调节作用逐渐得到关注。研究表明,该信号通路主要与下丘脑-垂体-肾上腺轴、神经炎症抑制及神经细胞焦亡调控密切相关。文章概述了中医药通过调节GR/NF-κB/NLRP3信号通路发挥抗抑郁作用的机制,以期为抑郁症的治疗和进一步研究提供理论依据。

    Abstract:

    Major Depressive Disorder (MDD) is one of the main causes of suicide. Monoamines, the mainstay of treatment for the disease, have limited efficacy, highlighting the urgent need for improved treatment. Traditional Chinese medicine (TCM) has shown the advantages of multiple mechanisms of action and fewer side effects in this field, which has become a potential treatment option. In recent years, the important regulatory role of GR/NF-κB/NLRP3 signaling pathway in the treatment of depression has gradually attracted attention. Studies have shown that this signaling pathway is mainly closely related to the hypothalamic-pituitary-adrenal axis, the inhibition of neuroinflammation and the regulation of nerve cell pyroptosis. This article reviews the mechanism of traditional Chinese medicine"s antidepressant effect by regulating GR/NF-κB/NLRP3 signaling pathway, in order to provide theoretical basis for the treatment and further research of depression.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2025-05-08
  • 最后修改日期:2025-06-05
  • 录用日期:2025-07-30
  • 在线发布日期:
  • 出版日期: